Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Earnings Per Share (EPS) : GAAP EPS of $0.74 for 2023, compared to $3.24 in 2022. Gross Margin : GAAP gross margin of 44.6% for 2023, compared to 56.9% in 2022. 2024 Financial Guidance : Total reported revenue projected to be $620M-$650M. Warning! GuruFocus has detected 4 Warning Sign with ALIT. On February 21, 2024, Repligen Corp ( NASDAQ:RGEN ) released its 8-K filing , detailing the company's financial results for the fourth quarter and full year of 2023. As a global life sciences company, Repligen is known for its bioprocessing technologies that serve biopharmaceutical companies and contract manufacturers worldwide. Despite a strong order book, the company faced a challenging year with a decline in both revenue and net income. Financial Performance Overview Repligen's total revenue for 2023 was $638.8 million, a significant decrease from $801.5 million in 2022. The company's net income also saw a sharp decline, falling to $41.6 million from $186.0 million in the previ
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen First Quarter 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at JPMorgan Chase & Co. from $230.00 to $200.00. They now have an "overweight" rating on the stock.MarketBeat
- Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Repligen (RGEN) Misses Q1 Earnings Estimates [Yahoo! Finance]Yahoo! Finance
RGEN
Earnings
- 5/1/24 - Miss
RGEN
Sec Filings
- 5/3/24 - Form DEFA14A
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- RGEN's page on the SEC website